VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,800 | -10.7% | 2,000 | 0.0% | 0.02% | -7.4% |
| Q2 2023 | $60,220 | -6.9% | 2,000 | 0.0% | 0.03% | -10.0% |
| Q1 2023 | $64,680 | +12.9% | 2,000 | 0.0% | 0.03% | +11.1% |
| Q4 2022 | $57,300 | +19.4% | 2,000 | 0.0% | 0.03% | +8.0% |
| Q3 2022 | $48,000 | -12.7% | 2,000 | 0.0% | 0.02% | -3.8% |
| Q2 2022 | $55,000 | -28.6% | 2,000 | 0.0% | 0.03% | -21.2% |
| Q1 2022 | $77,000 | +20.3% | 2,000 | 0.0% | 0.03% | +32.0% |
| Q4 2021 | $64,000 | +8.5% | 2,000 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $59,000 | -13.2% | 2,000 | 0.0% | 0.02% | -10.7% |
| Q2 2021 | $68,000 | +4.6% | 2,000 | 0.0% | 0.03% | 0.0% |
| Q1 2021 | $65,000 | -9.7% | 2,000 | 0.0% | 0.03% | -15.2% |
| Q4 2020 | $72,000 | -7.7% | 2,000 | 0.0% | 0.03% | -15.4% |
| Q3 2020 | $78,000 | +6.8% | 2,000 | 0.0% | 0.04% | +2.6% |
| Q2 2020 | $73,000 | +143.3% | 2,000 | +53.8% | 0.04% | +111.1% |
| Q1 2020 | $30,000 | – | 1,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |